Searchable abstracts of presentations at key conferences in endocrinology

ea0014p263 | (1) | ECE2007

The importance of (TAAAA)n polymorphism of SHBG gene in the metabolic syndrome

Xita Nektaria , Milionis Charalambos , Georgiou Ioannis , Elisaf Moses , Tsatsoulis Agathocles

Introduction: Sex hormone binding globulin (SHBG) levels have been associated with the development of the metabolic syndrome. In particular, low SHBG levels have been proposed as an indicator of increased risk for metabolic syndrome in men. The (TAAAA)n repeat polymorphism SHBG gene is believed to affect SHBG levels. In vitro experiments have shown that the allele with 6 TAAAA repeats is associated with decreased transcriptional activity of SHBG gene. The aim of this study was...

ea0011p675 | Reproduction | ECE2006

Evidence for synergy of SHBG and androgen receptor genes in PCOS phenotype

Xita N , Georgiou I , Psofaki V , Kolios G , Tsatsoulis A

Polycystic ovary syndrome (PCOS) is a common endocrinopathy with hyperandrogenemia to be its strongest genetically determined characteristic. Our aim was to investigate the potential synergy of two functional polymorphisms: the (TAAAA)n polymorphism of the sex hormone-binding globulin gene (SHBG) known to be associated with PCOS and influence serum SHBG levels (longer repeats were associated with lower SHBG levels) and the (CAG)n polymorphism of androgen receptor gene (...

ea0056p1071 | Thyroid (non-cancer) | ECE2018

Thyroid autoantibodies and quality of life in patients with benign thyroid diseases

Mintziori Gesthimani , Veneti Stavroula , Panagiotou Athanasios , Georgiou Thomas , Kita Marina

Objective: Thyroid autoimmunity has been proposed as a risk factor for impaired health-related Quality of Life (HRQoL), depression and anxiety, though evidence is still limited. The aim of the current study is to assess the association of thyroid autoimmunity with quality of life in patients with benign thyroid disease.Design: A cross-sectional study was implemented, that included consecutive patients with benign thyroid diseases who visited the outpatie...

ea0063p467 | Calcium and Bone 2 | ECE2019

Discovery of a novel NOTCH2 mutation causing Hajdu Cheney Syndrome in a kindred with remarkable phenotypic diversity

Efstathiadou Zoe , Kostoulas Charilaos , Polyzos Stergios , Kalograni Fani , Tirkalas Sotirios , Adamidou Fotini , Georgiou Ioannis , Kita Marina

Introduction: Hajdu Cheney Syndrome (HCS) is a rare genetic autosomal dominant disorder affecting multiple organ systems, characterized by distinctive facial features, acroosteolysis and severe osteoporosis. In a limited number of cases, the disease appears in association with polycystic kidney disease (PKD) or Crohn’s disease (CD). Splenomegaly has also been reported. Heterozygous gain-of-function mutations in NOTCH2 gene have been confirmed to be the cause of H...

ea0063p501 | Calcium and Bone 2 | ECE2019

A man with maxillary swelling and tertiary hyperparathyroidism

Pappa Dimitra , Thoda Pinelopi , Sakali Anastasia Konstantina , Georgiou Eleni , Gountios Ioannis , Bargiota Alexandra

Introduction: Tertiary hyperparathyroidism can be developed in cases of persistent or non-curable secondary hyperparathyroidism or in any other case of long-standing hypocalcemia that leads to the autonomous function of at least one parathyroid gland. We present a case of a man with tertiary hyperparathyroidism and excessive maxilla swelling and extensive bone lesions.Presentation: A 32 years old man, with chronic renal failure on dialysis for twelve yea...

ea0063p523 | Calcium and Bone 2 | ECE2019

Relapse of primary hyperparathyroidism concurrent with a plasma cell proliferative disorder: report of a case

Adamidou Fotini , Georgiou Thomas , Daikidou Dimitra , Sarafidis Pantelis , Komzia Paraskevi , Kita Marina

Introduction: Primary hyperparathyroidism associated with multiple myeloma has been rarely reported to coincide, but relapse of previously remitted primary hyperparathyroidism concurrent with a plasma cell proliferative disorder has not been described.Case report: A 76-year-old female was referred to the endocrine clinic for evaluation of primary hyperparathyroidism discovered incidentally during hospitalization for angina. She had a corrected calcium of...

ea0063p830 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

An uncommon case of a large adrenal cyst

Sakali Anastasia-Konstantina , Thoda Pinelopi , Pappa Dimitra , Georgiou Eleni , Gountios Ioannis , Bargiota Alexandra

Introduction: Adrenal cystic lesions are rare. Differential diagnoses include pseudocysts, echinococcal cysts, hemangiomas, cystic pheochromocytomas, adrenal hematomas and lymphangiomas. We present here a rare case of an adrenal lymphangioma.Case report: A 35-year old man was referred to our department for investigation of a right adrenal cystic mass, incidentally found during an abdominal ultrasound. The patient was completely asymptomatic and had a med...

ea0063p889 | Diabetes, Obesity and Metabolism 3 | ECE2019

Radiation-induced loss of glycemic control in a patient with refractory lymphoma

Adamidou Fotini , Komzia Paraskevi , Georgiou Thomas , Tsoutsas Georgios , Panagiotou Athanasios , Kita Marina

Introduction: PD-1 inhibitors are powerful disruptors of self- tolerance and autoimmune diabetes develops in up to 0.9% of patients. Lipodystrophic insulin reactions, although uncommon with human insulin analogs, are a recognized cause of impaired insulin delivery in patients on intensive insulin regimens. We describe a patient with resistant lymphoma and nivolumab-induced autoimmune diabetes, who suffered loss of glycemic control due to early radiation-induced subcutaneous fi...

ea0049ep68 | Adrenal cortex (to include Cushing's) | ECE2017

The role of dehydroepiandrosterone sulphate (DHEAS) in the evaluation of autonomous cortisol secretion in adrenal incidentalomas

Adamidou Fotini , Georgiou Thomas , Mintziori Gesthimani , Tsirou Efrosini , Anagnostis Panagiotis , Panagiotou Athanasios , Kita Marina

Introduction: Subclinical hypercortisolism (SH) has been reported in 5–20% of patients with adrenal incidentalomas (AIs), with various cardiometabolic consequences. We intended to investigate the contribution of DHEAS to standard testing, as another indicator of autonomous cortisol secretion in AIs.Materials and methods: Ninety consecutive patients (n=90) with AIs were included in a prospective cohort study. SH was diagnosed if ≥2 cri...

ea0049ep828 | Thyroid (non-cancer) | ECE2017

Management of very severe Graves’ orbitopathy with low dose rituximab: report of two cases

Adamidou Fotini , Manani Christina , Anagnostis Panagiotis , Georgiou Thomas , Boboridis Kostas , Kita Marina

Introduction: Although Graves’ orbitopathy (GO) is common in the course of Graves’ disease, dysthyroid optic neuropathy and corneal breakdown are rare. We describe two cases of severe GO treated successfully with rituximab.Case 1: A 50-year-old female smoker with Graves’disease, presented with disfiguring eyelid edema, exophthalmos and diplopia, preserved visual acuity and clinical activity score (CAS) ≥ 5. She received pulsed medrox...